Sol-Gel Technologies
SLGL | NASDAQ
$54.96
-$0.16 (-0.29%)
At close: Nov 16, 2026, 4:00 PM ET
$55.14
+$0.18 (+0.33%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-0.29%
(1D)No price chart data available for 1D timeframe.
Rating
23.2
Fundamentals Weak
Market Sentiment Neutral
Moat Narrow
Sector Rank #963/1021 (Top 94%)
Key Statistics
Market Data
Market Cap $179.94M
1D Range
53.98 58.43
52W Range
35.40 97.97
Valuation (TTM)
PE -10.51
PB 4.20
EV/EBITDA -7.78
Valuation (NTM)
Forward PE N/A
Forward PEG -0.01
Price Target $110.00
Cash Flow
FCF Yield 0.0%
SBC Adj. FCF Yield -1.2%
SBC Impact N/A
Margins
Gross Margin 97.1%
Operating Margin -1221.0%
FCF Margin 0.0%
Growth (CAGR)
Revenue 3Y | 5Y -4.8% |
-35.1%
Dil EPS 3Y | 5Y -94.5% |
-63.7%
FCF 3Y | 5Y 150.0% |
55.4%
Returns
ROA -31.9%
ROE -38.8%
ROIC -39.8%
Financial Health
Net Cash
$43.86M
Current Ratio 7.12
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Sol-Gel Technologies Ltd., a pharmaceutical firm currently in its clinical development phase, specializes in the creation and market introduction of skin-applied medications. These products leverage t...
Sector Healthcare
Industry Biotechnology
Employees 28
IPO Date Feb 1, 2018
Website www.sol-gel.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$1.72
Beat +16.91%
YoY:
+19.25% REV
$41K
Miss -72.67%
YoY:
-89.75%Next Earnings
Mar 17, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$110.00
Upside
+100.15%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove SLGL